TI
INO icon

Trexquant Investment’s Inovio Pharmaceuticals INO Stock Holding History

Trexquant Investment’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,525
Closed -$510K – 1526
2021
Q4 		$510K Buy
8,525
+4,664
+121% +$374K 0.03% 625
2021
Q3 		$332K Buy
+3,861
New +$387K 0.03% 700
2021
Q2 		– Sell
-6,060
Closed -$675K – 1284
2021
Q1 		$675K Buy
+6,060
New +$797K 0.06% 402
2018
Q1 		– Sell
-6,844
Closed -$339K – 1219
2017
Q4 		$339K Buy
+6,844
New +$424K 0.04% 685
2015
Q4 		– Sell
-14,602
Closed -$1.01M – 1141
2015
Q3 		$1.01M Buy
+14,602
New +$1.27M 0.09% 415

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trexquant Investment's INO Position: Q1 2022 in Review

Trexquant Investment sold out of Inovio Pharmaceuticals (INO) in Q1 2022, closing a stake of 8,525 shares — an estimated $510K sold.

Trexquant Investment first reported a position in INO in Q3 2015 and held it in 5 quarters. The position peaked at $1.01M in Q3 2015. 198 funds tracked by Wall St. Rank hold INO as of Q1 2022.

  • Trexquant Investment reported no remaining Inovio Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Trexquant Investment sold 8,525 Inovio Pharmaceuticals shares in Q1 2022, an estimated $510K.
  • Trexquant Investment first reported a position in Inovio Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Trexquant Investment's Inovio Pharmaceuticals position peaked at $1.01M in Q3 2015.
  • 198 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2022.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.